Literature DB >> 18792810

Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population.

Hamid Galehdari1, Atefeh Pooryasin, Alimohammad Foroughmand, Setareh Daneshmand, Mostafa Saadat.   

Abstract

Schizophrenia is a complex genetic disorder to which genetic variation in the glutamatergic signaling pathways is believed to play a substantial role in the etiology of the disease. Association studies have implicated the N-methyl-D-aspartate receptor subunit gene, GRIN1, as a candidate gene for schizophrenia. In this report, we used a case control study to establish the possible association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia in an Iranian cohort of 200 unrelated patients and 200 controls. The allelic and genotypic frequencies of the polymorphism were determined using polymerase chain reaction restriction fragment length polymorphism. Data analysis using logistic regression and the Mantel-Haenszel chi-square test revealed a strong association between the G1001C polymorphism and schizophrenia (CG genotype: odds ratio (OR) = 2.12, 95% confidence interval (CI) 1.34-3.48, P = 0.001 and CC genotype: OR = 29.10, 95% CI 3.40-565.78, P < 0.001). Furthermore, the C allele is significantly associated with an increasing risk of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792810     DOI: 10.1007/s12031-008-9148-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

Review 1.  Epidemiology of schizophrenia: the global burden of disease and disability.

Authors:  A Jablensky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

2.  Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness.

Authors:  Daryl E Fujii; A Michael Wylie; Jeffrey H Nathan
Journal:  Schizophr Res       Date:  2004-07-01       Impact factor: 4.939

Review 3.  Effects of mRNA untranslated regions on translational efficiency of NMDA receptor subunits.

Authors:  Antonius M J VanDongen; Hendrika M A VanDongen
Journal:  Neurosignals       Date:  2004 Jul-Aug

4.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

5.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium.

Authors:  S V Faraone; T Matise; D Svrakic; J Pepple; D Malaspina; B Suarez; C Hampe; C T Zambuto; K Schmitt; J Meyer; P Markel; H Lee; J Harkavy Friedman; C Kaufmann; C R Cloninger; M T Tsuang
Journal:  Am J Med Genet       Date:  1998-07-10

6.  Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.

Authors:  Hsien-Yuan Lane; Yue-Cune Chang; Yi-Ching Liu; Chih-Chiang Chiu; Guochuan E Tsai
Journal:  Arch Gen Psychiatry       Date:  2005-11

7.  Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene(GRIN1) in schizophrenic patients.

Authors:  Chao-Chun Hung; Hsiang-Yin Chen; Chia-Hsiang Chen
Journal:  Psychiatr Genet       Date:  2002-12       Impact factor: 2.458

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

9.  Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample.

Authors:  Alexander Georgi; Rami Abou Jamra; Katrin Klein; Angela Wolf Villela; Johannes Schumacher; Tim Becker; Torsten Paul; Christine Schmael; Susanne Höfels; Norman Klopp; Thomas Illig; Peter Propping; Sven Cichon; Markus M Nöthen; Thomas G Schulze; Marcella Rietschel
Journal:  Psychiatr Genet       Date:  2007-10       Impact factor: 2.458

10.  Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia.

Authors:  Ayako Tani; Rumiko Kikuta; Kanako Itoh; Akiko Joo; Hiroki Shibata; Hideaki Ninomiya; Nobutada Tashiro; Yasuyuki Fukumaki
Journal:  Schizophr Res       Date:  2002-11-01       Impact factor: 4.939

View more
  11 in total

1.  A Neural "Tuning Curve" for Multisensory Experience and Cognitive-Perceptual Schizotypy.

Authors:  Francesca Ferri; Yuliya S Nikolova; Mauro Gianni Perrucci; Marcello Costantini; Antonio Ferretti; Valentina Gatta; Zirui Huang; Richard A E Edden; Qiang Yue; Marco D'Aurora; Etienne Sibille; Liborio Stuppia; Gian Luca Romani; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 2.  Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.

Authors:  Ke Xu; Robert H Lipsky
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-21

3.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

4.  Additive effect of MTHFR and GRIN1 genetic polymorphisms on the risk of schizophrenia.

Authors:  Ali Mohammad Foroughmand; Hamid Galehdari; Atefeh Pooryasin; Tahereh Ajam; Seyed Reza Kazemi-Nezhad
Journal:  Mol Biol Res Commun       Date:  2015-01

5.  N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: A meta-analysis.

Authors:  Mostafa Saadat
Journal:  EXCLI J       Date:  2010-01-26       Impact factor: 4.068

6.  Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.

Authors:  Jennifer J Donegan; Angela M Boley; Jeremy P Glenn; Melanie A Carless; Daniel J Lodge
Journal:  PLoS One       Date:  2020-06-04       Impact factor: 3.240

7.  ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response.

Authors:  Juzoh Umemori; Keizo Takao; Hisatsugu Koshimizu; Satoko Hattori; Tamio Furuse; Shigeharu Wakana; Tsuyoshi Miyakawa
Journal:  BMC Res Notes       Date:  2013-05-21

8.  Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.

Authors:  Silvia Rossi; Valeria Studer; Alessandro Moscatelli; Caterina Motta; Giancarlo Coghe; Giuseppe Fenu; Stacy Caillier; Fabio Buttari; Francesco Mori; Francesca Barbieri; Maura Castelli; Valentina De Chiara; Fabrizia Monteleone; Raffaele Mancino; Giorgio Bernardi; Sergio E Baranzini; Maria G Marrosu; Jorge R Oksenberg; Diego Centonze
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia.

Authors:  Hitomi Matsuno; Kazutaka Ohi; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Yano-Umeda; Takeo Saneyoshi; Masatoshi Takeda; Yasunori Hayashi
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Influence of Genetic Variants of the N-Methyl-D-Aspartate Receptor on Emotion and Social Behavior in Adolescents.

Authors:  Li-Ching Lee; Ying-Chun Cho; Pei-Jung Lin; Ting-Chi Yeh; Chun-Yen Chang; Ting-Kuang Yeh
Journal:  Neural Plast       Date:  2015-12-24       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.